Journal of Medical Economics, Volume 15, Issue sup1 (2012)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 15, Issue sup1 (2012)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Volume 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Editorial

Editorial
Introducing the JME Special Issue on Cost-Effectiveness Analyses
Kenneth Lee
Pages: 1-2
Published online: 19 Nov 2012
CitationforIntroducing the JME Special Issue on Cost-Effectiveness Analyses | Full Text | References | PDF (53.7 KB)
  • 457 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Original Article

Article
Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada
D. Chau, D. L. Becker, M. E. Coombes, G. Ioannidis, J. D. Adachi & R. Goeree
Pages: 3-14
Published online: 16 Oct 2012
AbstractforCost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada | Full Text | References | PDF (237.5 KB)
  • 1459 Views
  • 24 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness analysis of pancreatin minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis
J.H. Morawski, A. Prüfert, A. van Engen, D. Foerster, S. Sander-Struckmeier, E. Małecka-Panas & R. Pezzilli
Pages: 15-25
Published online: 22 Oct 2012
AbstractforCost-effectiveness analysis of pancreatin minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis | Full Text | References | PDF (202.1 KB)
  • 1059 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Article
The cost-effectiveness of paliperidone extended release in Spain
M. Treur, E. Baca, J. Bobes, F. Cañas, L. Salvador, B. Gonzalez & B. Heeg
Pages: 26-34
Published online: 23 Oct 2012
AbstractforThe cost-effectiveness of paliperidone extended release in Spain | Full Text | References | PDF (406.5 KB)
  • 849 Views
  • 13 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness analysis of anti-muscarinic agents for the treatment of overactive bladder
Edward P. Armstrong, Daniel C. Malone & Cat N. Bui
Pages: 35-44
Published online: 08 Oct 2012
AbstractforCost-effectiveness analysis of anti-muscarinic agents for the treatment of overactive bladder | Full Text | References | PDF (516.3 KB)
  • 717 Views
  • 17 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness analysis of rosuvastatin vs generic atorvastatin in Spain
Vivencio Barrios, José M. Lobos, Adalberto Serrano, Max Brosa, Margarita Capel & Concha Álvarez Sanz
Pages: 45-54
Published online: 12 Sep 2012
AbstractforCost-effectiveness analysis of rosuvastatin vs generic atorvastatin in Spain | Full Text | References | PDF (144.3 KB) | Supplemental
  • 1944 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost-effectiveness of everolimus vs sunitinib in treating patients with advanced, progressive pancreatic neuroendocrine tumors in the United States
Roman Casciano, Maruit Chulikavit, Allison Perrin, Zhimei Liu, Xufang Wang & Louis P. Garrison
Pages: 55-64
Published online: 03 Sep 2012
AbstractforCost-effectiveness of everolimus vs sunitinib in treating patients with advanced, progressive pancreatic neuroendocrine tumors in the United States | Full Text | References | PDF (386.7 KB)
  • 1225 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access

Explore articles